Jersey City, NJ — Regenlab USA has secured $5,000,000.00 in new commercial financing for expansion opportunities in Jersey City. According to the company website, RegenLab is recognized as a global leader in medical biotechnologies, specializing in cellular therapies, manufactured in the USA. RegenLab is at the forefront of innovation, with an expertly designed medical device for the preparation of platelet rich plasma from the patient’s own blood. Regen A-PRP is FDA cleared and developed with a focus on product quality, patient safety, and preparation efficiency. Our patient-centered technology has led to over one million treatments worldwide using RegenLab products. As we look to the future, we are committed to guiding new standards for emerging categories within the field of regenerative medicine.

To learn more about Regenlab USA please visit: http://regenlabusa.com/

Company Contact:
Regenlab USA
800-220-9082

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.